VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly- Owned ABcann Medicinals. February 11, at am. Published by NCV. 11 hours ago VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly- Owned ABcann Medicinals adult-use products and services, today announces that the Company's subsidiary, ABcann Medicinals Inc. ("ABcann"). 6 hours ago VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly- Owned ABcann Medicinals. February 11, |. No Comments.
to Announces Sales Cannabis Cannabis ABcann Granted VIVO Oil Medicinals Wholly-Owned License
Niagara Perpetual Harvest Facility. Phase Two redevelopment is expected to be operational in the third quarter and the projected , sq. CannTrust is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive global pharma partner, Apotex Inc. We support ongoing patient education about medical cannabis and have a compassionate use program to support patients with financial needs.
For more information, please visit: The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances, including those relating to: Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with: Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information. Sybil Eastman at Strategic Objectives, Tel: T shorters in the deepest water.
Short sellers are waiting for an eventual pullback in what they believe is a bubble. Turn on any mainstream media outlet to hear comparisons to crypto and dotcom bubbles.
The dedicated shorters are banking on the probable idea that this type of sector wide growth is not sustainable over a long period of time. The danger the shorters face is that some of these companies will hold their value long term.
Shorters may begin to tire over time if the sector continues to heat up as the average cost to borrow stocks in the cannabis sector is a Here are the largest short positions on the TSX, three of the top eleven are cannabis companies. The biggest risk when it comes to shorting is the potential for loss is infinite. While shorting does seem like a profitable way to make money, betting against the wrong company could be devastating.
Take Canopy for example, If Canopy uses its 5 billion dollars from Constellation and builds the largest weed empire in the world that stretches across several continents and generates revenue that not only threatens other cannabis companies, but other industries as well namely pharma, alcohol and tobacco those shorters may be in for one hell of a ride. Copyright , High Energy Trading. The cannabis streaming and royalty business models are attractive for a few different reasons.
Right of first refusal for future expansion. For Phase 1 and Phase 2 build out…total sqft. The first three locations include: This location gives Wildflower products exposure to all the Facebook employees in New York as Facebook currently occupies almost half of the building. For further information, please contact: This trial should help answer many of these critical questions. We are grateful to Dr. And we commend Tilray for the development of this study drug which has the potential to help thousands of people who struggle with ET.
The TSX does not accept responsibility for the adequacy or accuracy of this release. In the last month infamous short outlet Citron has stated they are shorting: Q Namaste Technologies N. V The biggest risk when it comes to shorting is the potential for loss is infinite. Stay up to date with the latest news.
Until — kg over 4 yrs. Nestle Building — kg based on , sqft build out. Initial footprint of 30, sqft with additional facility of ,sq. Great White North Growers. GreenhouseCo — Peter Quring. In active discussion regarding their facility expansion. Forward-looking statements in this news release include: Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty.
Factors that could cause actual results or events to differ materially from current expectations include: The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Food and Drug Administration. This 30, square foot production facility sits on approximately 8.
Hempire has also advised they have secured additional ready-to-flower plants for a late season harvest with a unique genetic currently in high demand. Located in Humboldt County, California the property is 8. On site are five 5,gallon water tanks, a well and pump house and a 30 x 60 ft. The property is zoned for a 10, square foot medical and a 20, square foot recreational cannabis license.
Certain statements in this press release are forward-looking statements and are prospective in nature. The Expansion Plan will add a total of , square feet of production capacity to Acreage Pharms. Phase 3 has a target completion date of January with Phase 4 expected to be completed later in To date, Acreage Pharms has secured provincial supply agreements for the upcoming adult recreational markets in both British Columbia and Alberta, and is actively pursuing supply agreements in other provinces.
In preparation for legalization date, Invictus will be introducing four lifestyle-inspired cannabis brands for recreational users: For more information, please visit www.
Invictus is a global cannabis company offering a selection of products under a wide range of lifestyle brands. Our integrated sales approach is defined by five pillars of distribution including medical, recreational, international, Licensed Producer to Licensed Producer and retail. Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul Gene Simmonsas our Chief Evangelist Officer, and global branding agency Authentic Brands Group.
Invictus is expanding its cultivation footprint, with two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring , square feet of available grow space today with , expected by the end of and 1 million by end of The Company will earmark 50 per cent of production to the medical and recreational markets, respectively.
To ensure consistency in quality and supply, Invictus maintains all aspects of the growing process through its subsidiary, Future Harvest Development Ltd. Invictus drives sustainable long-term shareholder value through a diversified product portfolio with over 69 Health Canada approved strains and a multifaceted distribution strategy including medical, recreational, international and retail.
For more information visit www. This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including the potential production capacity of Invictus, are forward-looking statements and contain forward-looking information.
These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, Invictus will not be successful in reaching its potential production capacity, its production facilities will not be completed as anticipated, and licenses or approvals being granted on terms or timelines that are materially worse than expected by the Company.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. This amendment permits Pure Sunfarms to expand its cannabis production area to , square feet — half of the 1.
The newly licensed area is expected to be in full production by mid-October of this year. In July, Pure Sunfarms received its sales license from Health Canada, permitting it to sell cannabis produced in the Delta 3 greenhouse facility.
Pure Sunfarms expects to have the full 1. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms nine of which are now licensed optimized for year-round harvesting more than 85 harvests annually and an automated process line encompassing harvesting, trimming, drying and packaging.
Village Farms International, Inc. With more than years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient.
Village Farms produces and distributes fresh, premium-quality produce with consistency days a year to national grocers in the U. TBD is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements.
Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.
Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements.
When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities.
The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. With twice as many citizens as the U. There are also ten other countries that have legalized medical marijuana and several others that could pass recreational laws over the next few years.
APH acquired Nuuvera Inc. In addition to providing access to the lucrative Swiss market, the acquisition provided a 64, sq. The company plans to invest CHF4. In addition to its Swiss holdings, the company is one of five in the world to have GMP certification that enables it access to the lucrative German medical market, as opposed to waiting for the tender process. The company has already applied for a license and expects to receive approval during the third quarter to begin cultivation at a , sq.
This means that Maricann can sell cannabis products directly to the German government rather than to consumers or physicians. In late-August, the company also announced that its European nutraceutical subsidiary, MariPlant, commenced the harvest of about hectares of hemp in Germany. The company managed to collect nearly 3, kilograms of dried material from just four hectares so far, using innovative new equipment developed in Germany. Management believes that it will be able to dry up to 50, kilograms of wet hemp flower per day using these technologies.
And finally, the company also announced a non-binding term sheet to form a strategic joint venture with San Martino, a large scale agricultural giant in Piedmont, Italy. The two companies will develop a centre of excellence for cannabis products in conjunction with the University of Eastern Piedmont.
The initial focus will be on high-CBD products for the medical market, but ultimately, THC products for the European market when legal. With these revenue coming from only two large bulk supply orders, shareholders and investors could see further upside, especially as the company has made the decision to consciously preserve inventory ahead of recreational legalization later this year. The Company made the conscious decision to preserve inventory to meet demand for these strategic long-term sales channels.
The company was recently selected by The Ontario Cannabis Store to supply recreational product through its online store launching on October 17, These combined catalysts could help accelerate its future financial results.
With its growing footprint and upcoming recreational legalization, investors may want to take a closer look at the stock given that the market is currently assigning almost no value to its growing European operations. As it speaks for itself, see the below summary and find the link to the full report below.
Through these tolling agreements, the company will process raw cannabis into cannabis resin and finished oils. Management is developing relationships with a number of existing LPs whereby they will process raw cannabis into cannabis resin and finished oils. The company is also looking to develop white label products where it will provide clients with a finished oil or derivative product.
The raw material inputs will either be sourced internally or through the wholesale market. The company is currently capable of processing 6, kg of raw cannabis per month. Furthermore, with the new development of controlled-dose capsules made from extracted oil, it is believed that demand for concentrates and derivative products will overtake flower sales by Additionally, the Canadian government has promised the inclusion of cannabis derivatives in Health Canada legislation by end If the Canadian market follows some of the trends seen in the U.
The first initiative for Valens Farms is to complete a , square foot Phase 1 controlled-environment strain-segregated hybrid greenhouse as part of a large-scale indoor facility on the acre property through its joint venture with Kosha Projects Inc.
As per the agreement, Kosha will contribute the land and all facility development and construction costs. Valens is responsible for all design and outfitting inputs, budgetary guidance, consulting and advisory services during construction and development of the facility.
Valens Farms will operate the facility, producing premium quality cannabis and supercritical CO2-extracted cannabis oils. Phase 1 will be completed in a number of stages: Under the terms of the agreement, the company will purchase cannabis materials from Eticann for use in its proprietary extraction system. This strong cash position will also allow management to pursue strategic acquisitions and address potential working capital requirements. Mackie Capital Research Report Sept Relevium is focused on the development, acquisition, marketing and sale of consumer products that are derived from cannabis and industrial hemp and other ingredients that are generally accepted as safe.
The Company uses cannabinoids and ingredients that have achieved GRAS status generally accepted as safe to create brands that are sold via wholesale channels, retail channels and online distribution. Relevium markets its products as dietary supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals. The Company plans on unveiling a complete line of dietary supplements for consumers derived from Cannabis Sativa and Cannabis Indica. Relevium is also focused on developing a complete line of supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals.
Cautionary Note Regarding Forward-Looking Statements This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information.
Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals.
Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.
We seek safe harbor. The BlissCo team has been focused on scaling up its operations in preparation for commercialization by securing its oil production license , developing an e-commerce strategy , building its network of partners and other high-impact initiatives.
The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships. BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.
These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements.
Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.
The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.
The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. The company anticipates its Frankfurt listing imminently. He has held senior positions with Equinet AG, Bankhaus Sal Oppenheim largest European private bank at that time as head of global proprietary trading and managing partner at Proprietary Partners AG, a Swiss based hedge fund advisory company.
Importantly DGWA consults to various companies, investors, institutions and federal organizations regarding their investment strategy. There is significant interest within Europe for regulated medical cannabis companies and we believe Pure Global Cannabis is one of the most attractive companies listed today. Pure Global Cannabis will be of particular interest to European retail, institutional and strategic investors as many are seeking greater exposure to global cannabis revolution. Pure Global Cannabis Inc.
PRCNF is a vertically-integrated, growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, consumer packaged goods CPG , and supply chain experts. Follow pureglobalcanna on Twitter and Facebook and pureglobalcannabis on Instagram. Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements.
These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements.
These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law. A copy of this report may be obtained by contacting Investor Relations, MedMen Enterprises, at investors medmen.
Ashley McGrath, and Mr. Chris Buysen have joined the board of directors of the Company. John Cullen has resigned as a director of the Company and Dr. Management and the board of directors would like to thank Mr. He advises a number of public companies on a variety of matters including continuous disclosure and regulatory matters, reverse takeover transactions, initial public offerings and takeover bids.
Irwin is also a director and officer of several public companies. Kaushal sits on the boards of numerous public and private companies. McGrath has been involved in real estate development for 14 years as the President and Owner of Glencoe Developments Inc. He has overseen all aspects of the development business including land acquisition, finance and sales of over , square feet of development space.
He oversees the management of a large rental portfolio of residential and commercial real estate and is a shareholder in an agribusiness operating over , square feet of indoor livestock production as well as a 23, acre grain farm. Buysen has held numerous senior financial positions with reporting issuers over the past 15 years including his current role as Chief Financial Officer of the Company.
He has also held a leadership role in a multi-family office, advising high net worth families on investment, business and other financial matters. While funded capacity may have been the buzzword over the past couple of years, quality and distribution have become the most important considerations as the market comes online.
Everyone is starting from the same point when it comes to building a brand reputation in the new industry. SpeakEasy Cannabis Club Ltd. The podcast has already received over 51, listens and has global reach. SpeakEasy Cannabis Club represents a collective of the top growers in Canada, sharing decades of knowledge and experience to produce the finest product in the world.
Listen to the Podcast on The Green Scene. Marc Geen carried on the tradition of Sun-Rype by bringing together a collective of world-class growers with a lifetime of experience producing the best cannabis in the world.
SpeakEasy acts as an incubator that shares knowledge, resources, and operational expertise with these independent growers—a model similar to YCombinator in Silicon Valley. The result is a rich set of ultra-premium products, each with their own unique story behind them.
With everyone starting at the same point, the company is working on innovative packaging and branding that will set its products apart on store shelves. The combination of authenticity and product quality will ultimately determine which licensed producers succeed, with premium products commanding 66 percent higher prices in many markets. While the license has been pending, the company has been busy planning for its second phase of growth.
The team began an 80, sq. The goal is for everyone to work together in the same area without having to worry about the added logistics and complexity associated with managing a multi-province footprint. The post In-Depth Interview: Sutherland has a successful track record within the cannabis sector. His past achievements and contributions include holding the position of founding Chief Operating Officer of Bedrocan Cannabis Corp. The terms of the Units will remain the same as previously announced see news release dated July 10, White Sheep is a commercial operator and strategic investor in global cannabis assets with direct operational expertise in building successful, large-scale, automated cannabis grow facilities and meeting regulatory and compliance standards.
Asterion is a Canadian cannabis company with operations in Australia, specializing in organic medical cannabis with a goal of becoming an industry leader in next generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality, genetically uniform cannabis strains, at an affordable price. The Company is led by a team of highly experienced executives with over years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.
Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the biotechnology or medical cannabis industry and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company.
These forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.
Although the Company believes that the statements, beliefs, plans, expectations, and intentions contained in this news release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations, or intentions will prove to be accurate. Readers should consider all of the information set forth herein and should also refer to other periodic reports provided by the Company from time-to-time. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.
Further detail on the offering is below. Flowr, through its subsidiaries, is a vertically-integrated cannabis company and Health Canada Licensed Producer that currently offers premium quality cannabis under the FlowrRx brand in the Canadian medicinal market. The Company has agreements with several provinces to provide its Flowr brand premium cannabis for sale in province-controlled adult-use retail channels following the expected October 17, legalization of adult recreational use in Canada.
Flowr expects the facility to reach full capacity in , targeted to be in excess of 12, kilograms annually. The Company is also building a 50, square foot research and development facility integrated into its Kelowna campus and funded through an exclusive alliance with the Hawthorne Gardening subsidiary of The Scotts Miracle-Gro Company NYSE: The Offering was comprised of both a brokered and a non-brokered financing.
The Subscription Receipts sold as part of the brokered financing were sold pursuant to the terms of an agency agreement dated August 28, among the Company, Needle, Clarus Securities Inc. The Company and Needle are currently working on the documentation to complete the Transaction, which is expected to close on or prior to September 10, Upon completion of the Transaction, it is intended that the net proceeds from the Offering will be used for facility expansion, marketing initiatives, capacity expansion, working capital and general corporate purposes.
All securities of Flowr issued pursuant to the Offering are subject to a hold period ending on the later of: Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon.
Trading in the securities of Flowr should be considered highly speculative. The Needle Capital Corp. The Company was incorporated on June 1, , and is headquartered in Calgary, Alberta.
Flowr, through its subsidiaries, is a vertically-integrated Canadian cannabis company focused on the natural science of cannabis. With a sense of craftsmanship and a spirit of innovation, Flowr is also well positioned with a line of premium quality cannabis products for the upcoming adult-use market.
This news release contains certain forward-looking statements that reflect the current views or expectations of management of Flowr and Needle with respect to performance, business and future events, including but not limited to express or implied statements and assumptions regarding completion of the Transaction and the use of proceeds from the Offering.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: Such factors include, among others: Flowr cautions that the foregoing list of material factors is not exhaustive.
Flowr has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events.
However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Flowr as of the date of this press release and, accordingly, is subject to change after such date.
Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Flowr does not undertake to update this information at any particular time except as required in accordance with applicable laws.
The post The Flow Corp. We strongly believe that our planned approach to cannabis oil will reinforce this position, and that our customers will appreciate the quality and value of these products. JWC intends to offer its newly developed medical cannabis oil products, in varying content and size configurations in anticipation of patient and customer demands. Aphria is an LP of medical cannabis in Canada. The company also has product for the recreational market as it signed supply agreements with provinces to provide adult-use products.
The producer also holds aspirations internationally thanks to recent acquisitions in Latin America. Next on our list is Aurora Cannabis, another Canadian producer making waves in the market thanks to its aggressive acquisition strategy.
In the company kicked into high gear by acquiring two fellow TSX-listed cannabis producer and gaining stakes into several ventures surrounding the overall industry. Aurora is working on the development of new facilities that will allow the company to properly supply provinces of recreational product and its patients of medical cannabis. CannTrust hosts a suite of recreational brands it plans to deploy once the market opens in Canada.
Canopy has left little doubt of its leading position in the Canadian market as a cannabis company. The moves Canopy makes often can affect sentiment on the overall space. This deal kicked off a massive rush in the space and has offered experts a reference point for the maturity of the emerging sector. Canopy holds supply agreements across the country to guarantee the presence of its products in the entire adult-use market. Formerly known as Hydropothecary this Quebec-based LP has grown alongside the cannabis market as it prepares for legalization.
TPX to create a joint venture to develop cannabis infused beverages, a popular trend item among cannabis companies for the time infused products become legal. InMed is developing therapies for patients through the research of cannabinoids in combination with drug delivery systems. The company has a dermatology product with clinical trials planned all throughout The stock has continued to grow over the year and despite a setback due to local policy in the area where an additional facility is set to be completed.
Through a partnership with Emerald Health Therapeutics, the food giant assembled a low-cost cannabis production venture. The company would offer a greenhouse facility in BC set to be converted into licensed production space. This listing offers a variety of Canadian cannabis investment opportunities with stocks ranging from growers to biotech companies examining therapies with cannabis.
The company employs a system of streaming investment into other cannabis ventures in the space. Auxly now seeks a strategy of building a vertically integrated cannabis company thanks to its incoming product and the production of its subsidiary Dosecann and the multiple deals it has secured across the industry. BLOCKStrain is a software company working on a blockchain-based platform for supply chains management in the cannabis industry.
The company has signed deals with cannabis producers WeedMD and Abattis Bioceuticals for the use of its platform. Delta 9 is a Canadian licensed producer based in Manitoba, a province in which the producer will be able to set up four shops by the end of The company has explored opportunities to develop the medical side as well, as it signed an agreement for the exclusive rights of a novel patented delivery method for cannabis through a dermal spray.
The producer managed to lock down a supply agreement with the Ontario Cannabis Store OCS and the Alberta Gaming, Liquor and Cannabis Commission for its products to offer products to the recreational market in the province.
As a fellow licensed producer Emerald Health sells medical cannabis to patients including oil products. It also conducts research and development into the characterization of cannabis strains and cultivation technologies. The company obtained supply agreements with Ontario, Newfoundland and Labrador for the upcoming recreational cannabis market.
FluroTech is a technology company working on a cost-effective testing platform for the cannabis industry at large. Harvest One conducts its business thanks to three different units, United Greeneries provides the horticultural arm while Satipharm AG serves the medical arm. Those two are under the Harvest One umbrella. Each business is strategically located with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation license.
ICC is a cannabis producer in Uruguay with assets in Colombia. The company made its public debut in the Canadian exchange creating a new opportunity for investors to gain exposure into new cannabis markets directly. Through an acquisition, this company holds a licensed producer with an indoor cannabis facility in Ontario. The company is building an expansion for its London, Ontario facility set to be completed in and result in an estimated 3, kilograms of dry flower per year as well as process cannabis into oils.
The company even announced the completion of its first shipment of product. Simmons has toured cannabis shows speaking in behalf of the company and the cannabis industry. JWC is a premium cannabis brand company with an LP as a subsidiary. The company differentiates itself as it grows cannabis through a proprietary aeroponic platform named GrowthstormTM. The company has indicated its intentions to pursue a retail play through in Ontario with the creation of JWC branded stores.
Next on our stock list for cannabis investment is Kalytera. This clinical-stage pharmaceutical is working on developing the latest in therapies available through the use of cannabis. Kalytera is developing a new class of proprietary CBD therapeutics. The producer has declared it will seek to expand its presence through Latin America including in Mexico. Former Mexican president Vicente Fox has even joined the board of directors for the company. In its own words LiveWell is a nutritional lifestyle company looking to develop health products for patients and consumers in the cannabis and hemp space.
The company has indicated it plans to distribute cannabis edibles and infused products once they become legal in Canada. Namaste is a unique company in its business as it relates to the cannabis space. The company hosts an online and app-based platform that connects patients to physicians giving cannabis medicine and then offering the sale of licensed product in Canada.
The company has signed supply agreements to purchase bulk cannabis product in order to offer a variety of products through its Cannmart subsidiary. NAC is a unique play for cannabis investors.
SCU which has indicated it plans to revamp some of its existing coffee stores across the country into cannabis shops. Naturally Splendid has a slightly different focus than some of the other companies here on the Canadian cannabis stocks list. Rather than being involved in the medical marijuana space, the company offers investors exposure to the hemp-based healthy foods, omega, and cannabinoid markets.
Newstrike is a company focussed on recreational brands and products. The company has attempted to raise the visibility of its name thanks to a partnership with Canadian rock band The Tragically Hip.
However, the company has secured supply agreements with provinces making sure its product will be on store shelves and online for adult-use. As its name suggests, OrganiGram specializes in producing organically grown medical marijuana. Radient is an extraction technology company that has dabbled in the cannabis sector thanks to a partnership with licensed producer Aurora Cannabis. This company shows the wide range of the cannabis space as Tetra focuses on the development of novel technologies with cannabis through research studies.
Tetra has launched a study approved by Health Canada pitting its medical cannabis product against the effectiveness of opioids in the management of breakthrough cancer pain. Supreme has also become a wholesale supplier of cannabis products securing sales among other cannabis companies.
Supreme has guaranteed a presence for 7ACRES product across Canada with supply agreements for the start of recreational use. Viridium acts as the parent company for Experion Biotechnologies a Canadian licensed producer of cannabis.
The company currently counts with three brands of products to appeal consumers. VIVO Cannabis earned supply agreements with Ontario and Alberta, which guarantee the presence of its products on these markets once recreational use becomes legal in Canada. Another officially licensed producer in Canada, WeedMD is focused on the growth of medical cannabis and sells its product directly to customers through their website. After a failed partnership with Hiku Brands, the company focussed its effort into the recreational market and earned supply agreements with provinces in Canada to provide its products for legalization.
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products, including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets. In its attempt to scale up on the cannabis market from a regional, national and international scope, ACG has moved to develop a Cannabis Botany Centre with Botanical Research In Motion International to jointly develop and operate multiple cannabis-focused Botany centers in Canada.
Beleave is a biotech company with an entry into the medical cannabis market through its licensed producer subsidiary Beleave Kannabis. The company also plans to host a retail presence in Saskatchewan as it secured store locations. The company is seeking to be a high-volume distributor, processor and packager of medical cannabis.
The company seeks to support the growth of other companies through cash flow from operations, strategic acquisitions and partnerships. On the technology side of things, Cannabix Technologies is developing a breathalyzer device and technologies to aid law enforcement detect impaired driving from cannabis. Canntab is offering investors a different type of play into the cannabis market. The company develops cannabis oral dosage formulations thanks to exclusive technology working in the medical cannabis space.
Cannvas is a technology company with data-driven business solutions to the industry. This vertically-integrated company with operations in California and Puerto Rico. Choom Holdings is a brand focussed cannabis company seeking to open its own network of retail shops in the Canadian West Coast. The company is also in the running for its subsidiaries to obtain licenses for the legal production of cannabis. CannaRoyalty puts together its platform of holdings through royalty agreements, equity interests, convertible debt and licensing agreements across Canada and the US.
The multi-state operator has indicated it plans to bring its brands into the Canadian market following legalization in the country. CROP works with cannabis companies to offer capital for the acquisition of land real estate, branding and infrastructure for operations in the cannabis investment space. This year the company has obtained 30 percent interest in facilities located in California and Washington State.
10 hours ago BRIEF-VIVO Cannabis Announces Cannabis Oil Sales License Granted To Wholly-Owned Abcann Medicinals. 10 hours ago Amendment to production license allows for sale of cannabis oil Granted to Wholly-Owned ABcann Medicinals at New Cannabis Ventures. 11 hours ago Inc. (VVCIF: OTCQX International) | VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly-Owned ABcann Medicinals.